Business Description
Human Metabolome Technologies Inc. is a Japanese biotechnology company founded in 2003 and headquartered in Tsuruoka, Japan, specializing in the study of metabolites to support drug discovery, medical diagnosis, and food production. The company offers a broad range of analytical services, including the identification of biomarkers such as Phosphorylethanolamine, which shows promise in detecting major depressive disorder through blood plasma testing. Its work spans areas such as cancer research, infectious diseases, nutrition, and microbiome science, serving both research and clinical settings. The company works alongside the Institute for Advanced Biosciences and Keio University to further advance metabolome analysis technology.
